» Articles » PMID: 32983181

Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2

Overview
Journal Front Immunol
Date 2020 Sep 28
PMID 32983181
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The response to the SARS-CoV-2 coronavirus epidemic requires increased research efforts to expand our knowledge of the disease. Questions related to infection rates and mechanisms, the possibility of reinfection, and potential therapeutic approaches require us not only to use the experimental models previously employed for the SARS-CoV and MERS-CoV coronaviruses but also to generate new models to respond to urgent questions.

Development: We reviewed the different experimental models used in the study of central nervous system (CNS) involvement in COVID-19 both in different cell lines that have enabled identification of the virus' action mechanisms and in animal models (mice, rats, hamsters, ferrets, and primates) inoculated with the virus. Specifically, we reviewed models used to assess the presence and effects of SARS-CoV-2 on the CNS, including neural cell lines, animal models such as mouse hepatitis virus CoV (especially the 59 strain), and the use of brain organoids.

Conclusion: Given the clear need to increase our understanding of SARS-CoV-2, as well as its potential effects on the CNS, we must endeavor to obtain new information with cellular or animal models, with an appropriate resemblance between models and human patients.

Citing Articles

Impact of SARS-CoV-2 on the male reproductive tract: insights from semen analysis and cryopreservation.

Giugliano S, Mozzarelli A, Navarra A, De Simone G, Rescigno M, Levi-Setti P J Assist Reprod Genet. 2024; 42(2):577-587.

PMID: 39699717 PMC: 11871218. DOI: 10.1007/s10815-024-03321-4.


modelling of neuron signal impact of cytokine storm-induced demyelination.

Adonias G, Siljak H, Balasubramaniam S, Barros M Open Biol. 2024; 14(9):240138.

PMID: 39226928 PMC: 11371429. DOI: 10.1098/rsob.240138.


Recent and advanced nano-technological strategies for COVID-19 vaccine development.

Nwagwu C, Ugwu C, Ogbonna J, Onugwu A, Agbo C, Echezona A Methods Microbiol. 2024; 50:151-188.

PMID: 38620863 PMC: 9015106. DOI: 10.1016/bs.mim.2022.03.001.


Identification of Factors Associated with Mortality in the Elderly Population with SARS-CoV-2 Infection: Results from a Longitudinal Observational Study from Romania.

Birlutiu V, Neamtu B, Birlutiu R Pharmaceuticals (Basel). 2024; 17(2).

PMID: 38399417 PMC: 10891894. DOI: 10.3390/ph17020202.


Viral Entry Inhibitors Protect against SARS-CoV-2-Induced Neurite Shortening in Differentiated SH-SY5Y Cells.

Mignolet M, Gilloteaux J, Halloin N, Gueibe M, Willemart K, De Swert K Viruses. 2023; 15(10).

PMID: 37896797 PMC: 10611151. DOI: 10.3390/v15102020.


References
1.
Rabaan A, Al-Ahmed S, Haque S, Sah R, Tiwari R, Singh Malik Y . SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez Med. 2020; 28(2):174-184. View

2.
Guo D, Zhu Q, Zhang H, Sun D . Proteomic analysis of membrane proteins of vero cells: exploration of potential proteins responsible for virus entry. DNA Cell Biol. 2013; 33(1):20-8. PMC: 3880917. DOI: 10.1089/dna.2013.2193. View

3.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

4.
Barrett P, Mundt W, Kistner O, Howard M . Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Rev Vaccines. 2009; 8(5):607-18. DOI: 10.1586/erv.09.19. View

5.
Bhatia H, Singh H, Grewal N, Natt N . Sofosbuvir: A novel treatment option for chronic hepatitis C infection. J Pharmacol Pharmacother. 2014; 5(4):278-84. PMC: 4231565. DOI: 10.4103/0976-500X.142464. View